Related Experiment Video
Updated: Aug 6, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
Functional constipation in children: What physicians should know
Duc Long Tran1,2, Palittiya Sintusek3
1Thailand and Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Bangkok, Thailand.
Insights
Functional constipation (FC) affects 14.4% of children globally. While osmotic laxatives are common, adherence and parental concerns hinder treatment, necessitating exploration of novel therapies.
Area of Science:
- Pediatrics
- Gastroenterology
- Pharmacology
Background:
- Functional constipation (FC) is the most prevalent functional gastrointestinal disorder in children, with a global prevalence of 14.4% based on Rome IV criteria.
- Its multifactorial pathophysiology complicates management, with osmotic laxatives and toilet training being the primary treatments.
- Treatment failure is often linked to children's medication adherence and parental concerns about long-term laxative use.
Purpose of the Study:
- To provide a comprehensive overview of functional constipation in children.
- To review global prevalence, pathogenesis, diagnostic criteria, and management strategies for pediatric FC.
- To explore both conventional and emerging therapeutic options for functional constipation.
Main Methods:
- Systematic review of existing literature on pediatric functional constipation.
- Analysis of diagnostic criteria, including Rome IV criteria.
- Evaluation of pharmacological and non-pharmacological treatment options, including novel therapies.
Main Results:
- Osmotic laxatives, alongside toilet training, are the current mainstay treatment for pediatric functional constipation.
- Novel therapies including probiotics, synbiotics, and specific receptor agonists show promise but require further research.
- Non-pharmacological approaches like dietary changes and physiotherapy are important, with surgery reserved for refractory cases.
Conclusions:
- Functional constipation is a common childhood disorder requiring multifaceted management approaches.
- Adherence and parental concerns are key challenges in current treatment paradigms.
- Further research into novel therapies and personalized treatment strategies is crucial for improving outcomes in pediatric functional constipation.
Abstract:
Functional constipation (FC) is considered the most common functional gastrointestinal disorder in children with a pooled global prevalence of 14.4% (95% confidence interval: 11.2-17.6) when diagnosed based on the Rome IV criteria. Its pathophysiological mechanisms are thought be multifactorial and complicated, resulting in difficult management. Currently, the most effective medication, when used in parallel with toilet training, is osmotic laxatives. Children's adherence to medication and parental concern regarding long-term laxative use are the main contributors to treatment failure. Recently, novel therapies with a high safety profile have been developed, such as probiotics, synbiotics, serotonin 5-hydroxytryptamine 4 receptor agonists, chloride channel activators, and herbal and transitional medicines; nonetheless, well-designed research to support the use of these therapies is needed. This review aims to focus on multiple aspects of FC in children, including global prevalence, pathogenesis, diagnostic criteria, tools, as well as conventional and novel treatment options, such as non-pharmacological management, including adequate fiber and fluid intake, physiotherapy, or neuromodulators. We also report that in very difficult cases, surgical intervention may be required.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

